Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers

BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, widely used in the treatment of motion-sickness. The pharmacokinetic parameters of DOM make it a suitable candidate for development of Solid Lipid Nanoparticle (SLN) and Nanostructured Lipide Carrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Thatipamula, RP., Palem, CR., Gannu, R., Mudragada, S., Yamsani, MR.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232070/
https://www.ncbi.nlm.nih.gov/pubmed/22615636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232070/
https://www.ncbi.nlm.nih.gov/pubmed/22615636

Ejemplares similares